Metformin as a new anti-cancer drug in adrenocortical carcinoma

Adrenocortical carcinoma (ACC) is a rare heterogeneous malignancy with poor prognosis. Since radical surgery is the only available treatment, more specific and effective drugs are urgently required. The anti-diabetic drug metformin has been associated with a decreased cancer prevalence and mortality...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Poli, Giada, Cantini, Giulia, Armignacco, Roberta, Fucci, Rossella, Santi, Raffaella, Canu, Letizia, Nesi, Gabriella, Mannelli, Massimo, Luconi, Michaela
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2016
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5226535/
https://ncbi.nlm.nih.gov/pubmed/27391065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10421
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia